Ravelcare logo

Ravelcare

Listed

IPO Timeline

Issue open date

1 Dec 2025

Issue close date

3 Dec 2025

UPI mandate deadline

3 Dec 2025

Allotment finalization

4 Dec 2025

Refund initiation

5 Dec 2025

Share credit

5 Dec 2025

Listing date

8 Dec 2025

Mandate end date

18 Dec 2025

Lock-in end date for anchor investors (50%)

3 Jan 2026

Lock-in end date for anchor investors (remaining)

4 Mar 2026

Grey Market Premium Trend

₹75
Current GMP
₹205
Est. Listing Price
57.7%
Est. Listing Gain
₹123 - ₹130
Price Band

GMP History

DateGMP (₹)Est. Listing Price (₹)Est. Listing Gain
7 Dec₹75₹20557.69%
6 Dec₹75₹20557.69%
5 Dec₹75₹20557.69%
4 Dec₹75₹20557.69%
3 Dec₹75₹20557.69%
2 Dec₹80₹21061.54%
1 Dec₹80₹21061.54%
30 Nov₹52₹18240.00%
29 Nov₹40₹17030.77%
28 Nov₹15₹14511.54%
27 Nov₹14₹14410.77%
26 Nov₹16₹14612.31%
25 Nov₹16₹14612.31%
24 Nov₹14₹14410.77%
23 Nov₹0₹1300.00%
22 Nov₹0₹1300.00%

Key Dates

Open
1 Dec 2025
Close
3 Dec 2025
Listing
8 Dec 2025

Quick Stats

Issue Size:24cr
Lot Size:1000 shares

About the Company

Ravelcare Limited is a digital-first beauty and personal care company offering haircare, skincare, and bodycare products through a direct-to-consumer model. Originally incorporated in 2018 as Ravelcare Private Limited, the company was converted into a public limited entity in June 2024. Its product lineup is developed using data-driven insights and sold through multiple channels including its website, major e-commerce platforms like Amazon, Flipkart and Myntra, and quick-commerce platform Blinkit. The company has also expanded internationally and now caters to customers in the UAE, Australia, Canada, Germany, the USA and Saudi Arabia.

Strengths

  • Digital-first D2C distribution model with strong presence across e-commerce platforms.
  • Focus on personalized formulations developed through data-driven R&D collaboration with external labs.
  • Wide product portfolio across haircare, skincare, bodycare and scalp care with strong revenue share from haircare.
  • Growing international footprint with sales initiated in UAE, Australia, Canada, Germany, USA and Saudi Arabia.
  • High EBITDA and PAT margins indicate strong operating efficiency and profitability.

Risks

  • Complete dependence on a single third-party contract manufacturer for all products.
  • Rising product acquisition cost from the manufacturer may directly impact margins and selling prices.
  • Contract manufacturer also manufactures for other brands and may create conflict of interest.
  • Lack of in-house manufacturing exposes the company to disruption risk from equipment failures, labour issues and compliance lapses at vendor facilities.
  • Inadequate IP protection may lead to imitation or misuse of formulations by the manufacturer or third parties.

Ravelcare IPO – Frequently Asked Questions

  • The price band for the Ravelcare IPO is set at ₹123 to ₹130 per share.
  • The Ravelcare IPO opens on December 1, 2025 and closes on December 3, 2025.
  • The tentative listing date for the Ravelcare IPO is December 8, 2025.
  • You can apply for the Ravelcare IPO via your broker or bank using ASBA or UPI. Log in to your trading app (Zerodha, Upstox, Groww, etc.), select IPO section, choose Ravelcare, enter lot quantity and UPI ID, then approve the mandate.
  • The lot size for the Ravelcare IPO is 1000 shares. Investors must apply for at least one lot (i.e., 1000 shares).